United Kingdom · Funded startup
Funding summaryUpdated 26 Oct 2026
$377Mraised across 7 rounds since 2018, from 7 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by UCL Technology FundSEC filing: $34M sold, first sale Mar 2023
Source recordedSEC filing: $34M sold, first sale Mar 2023
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yetSEC filing: $150M sold, first sale Feb 2021
Venrock
Temasek Holdings
Cormorant Capital
ArrowMark Partners
Cowen Group
Perceptive VenturesReported by FinSMEs
Orchard Therapeutics filed 8 raises, $402M in all. Filings say how much was sold and to how many investors; they never name the investors.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
RA Capital ManagementLTemasek HoldingsCowen GroupVenrock
Perceptive Advisors
Cormorant Asset Management
Foresite CapitalBaillie GiffordCormorant CapitalArrowMark PartnersMissing a round, or an investor who was in one? Tell us.
Orchard Therapeutics's investors include RA Capital Management, Temasek Holdings, Cowen Group, Venrock and Perceptive Advisors, and 17 more on record. RA Capital Management led its latest round.
Orchard Therapeutics has raised $377M across 7 rounds since 2018.
Orchard Therapeutics's most recent round was an Undisclosed round of $188M in Mar 2023, led by RA Capital Management.
Its most recent round, $188M in Mar 2023, is also its largest on record.
Orchard Therapeutics's first round on record, in Aug 2018, was backed by Venrock, Temasek Holdings and Baillie Gifford and 12 others.
Orchard Therapeutics's latest named round is an Undisclosed round, in Mar 2023.
Orchard Therapeutics is based in the United Kingdom.
RA Capital Management led the Undisclosed round in 2023.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United Kingdom · 
